Featured Research

from universities, journals, and other organizations

Research Uncovers A Key To Aging And Lifespan Determination

Date:
June 2, 1998
Source:
University Of Toronto
Summary:
A research team has identified a critical weakness in the defence against aging after increasing the life expectancy of fruit flies by 40 per cent by injecting them with a human gene known to be a key factor affecting aging and lifespan.

TORONTO -- A research team led by Dr. Gabrielle Boulianne of The Hospital for Sick Children (HSC) and the University of Toronto (U of T) and Drs. John Phillips and Arthur Hilliker of the University of Guelph has identified a critical weakness in the defence against aging. Using the fruit fly as a model biological system, the researchers discovered that a specific cell type -- the motor neuron -- is the major target for oxidative damage, known for several years to be a key factor affecting aging and lifespan. The researchers were able to boost the flies' defences by inserting a human gene which is known to protect against oxidative damage. As a result, the average lifespan of the flies (usually about 80 days) was increased by 40 percent. Their research is reported in the June issue of the scientific journal Nature Genetics.

"This research is significant because it clears up a long-standing mystery: which cells, when targeted by oxidative damage, limit the lifespan of the entire organism," says Dr. Boulianne, a scientist at HSC and an associate professor of Molecular and Medical Genetics at U of T. "In addition, we now know that just one gene, targeting one type of cell, has a huge impact on aging. Contrary to what was previously thought that many different factors contribute to aging, it now appears that the process may be simpler."

By inserting the human gene SOD1 (superoxide dismutase) into flies, researchers were able to protect the flies against oxidative damage. This damage, which increases with aging, affects a cell's ability to maintain its structure and function.

"One of life's ironies is that the stuff that we need to survive oxygen is actually toxic," explains Dr. Phillips. "When we breathe, toxic byproducts called oxygen radicals are created. Our cells defend against these toxins by either neutralizing or eliminating them. But as we age it becomes more difficult for our cells to cope with the toxins and they accumulate. What we now know is that the nervous system is the most vulnerable to this accumulation because it uses a lot of oxygen."

Oxidative damage has been linked to several human neurodegenerative diseases, including familial Amyotrophic Lateral Sclerosis, Huntington's disease, Parkinson's disease, and Alzheimer's disease.

"Of course, much more research needs to be done in the area of oxidative damage to the motor neurons," explains Dr. Boulianne. "The tools are still being developed that will allow us to selectively target cells in the nervous systems of mice or humans."

In addition to developing the necessary tools, the next steps in this field of research will include identifying other types of cells that are equally important in the aging process. Researchers will also attempt to determine if there are other beneficial actions that can be taken to affect oxygen metabolism.

This research was supported by The Hospital for Sick Children Foundation and grants from the Medical Research Council of Canada and the Natural Sciences and Engineering Research Council of Canada.

Contact:

Liz Leake, Public AffairsThe Hospital for Sick Children416-813-5046liz.leake@sickkids.on.ca

For more information about The Hospital for Sick Children, please visit our website: http://www.sickkids.on.ca


Story Source:

The above story is based on materials provided by University Of Toronto. Note: Materials may be edited for content and length.


Cite This Page:

University Of Toronto. "Research Uncovers A Key To Aging And Lifespan Determination." ScienceDaily. ScienceDaily, 2 June 1998. <www.sciencedaily.com/releases/1998/06/980602075755.htm>.
University Of Toronto. (1998, June 2). Research Uncovers A Key To Aging And Lifespan Determination. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/1998/06/980602075755.htm
University Of Toronto. "Research Uncovers A Key To Aging And Lifespan Determination." ScienceDaily. www.sciencedaily.com/releases/1998/06/980602075755.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins